Clinical Core

项目总结-临床核心（CC） 临床核心（CC）对印第安纳州阿尔茨海默病研究中心（IADRC）的功能至关重要。 一个主要的重点是确定和临床特征的患者与临床前和早期症状阶段 AD，包括早发和晚发AD，以及无症状、早期症状和受累个体 来自遗传性AD、遗传性不同的非AD痴呆和目前登记的散发性 额颞叶痴呆病例协调委员会将支持NACC、NCRAD和其他地方、区域、国家和国际组织， 通过获得和促进神经成像数据以及血液的银行和存储， DNA、外周血RNA、血浆、血清、CSF、外周血单核细胞（PBMC）和尸检 从我们的研究参与者的大脑样本，以进一步表征的神经影像核心（NIC）， 遗传学、生物标志物和生物标本核心（GBBC）、神经病理学核心（NPC）和数据管理 统计核心（DC）CC的患者将酌情参加ADNI、DIAN， LOAD、研究药物试验和其他当地和多中心研究。此外，我们将与 研究教育部分（REC）和外联，招聘和参与（OREC）核心 向各级研究人员和受训人员提供教育和培训机会， 支持受影响的参与者，家庭成员和整个社区。

Project Summary – Clinical Core (CC) The Clinical Core (CC) is critical to the function of the Indiana Alzheimer’s Disease Research Center (IADRC). A major emphasis is to identify and clinically characterize patients with preclinical and early symptomatic stages of AD, including early and late onset AD, as well as asymptomatic, early symptomatic, and affected individuals from families with hereditary AD, genetically distinct non-AD dementia, and the presently enrolled sporadic frontotemporal dementia cases. The CC will support NACC, NCRAD and other local, regional, national and international projects by obtaining and facilitating the banking and storage of neuroimaging data as well as blood, DNA, peripheral blood RNA, plasma, serum, CSF, peripheral blood mononuclear cells (PBMC) and postmortem brain samples from our research participants for further characterization by the Neuroimaging Core (NIC), Genetics, Biomarker, and Biospecimen Core (GBBC), Neuropathology Core (NPC) and the Data Management and Statistical Cores (DC). Patients from the CC will be offered as appropriate participation in ADNI, DIAN, LOAD, investigational drug trials and other local and multicenter research studies. In addition, we will collaborate with the Research Education Component (REC) and the Outreach, Recruitment, and Engagement (OREC) Core to provide education and training opportunities to researchers and trainees at all levels and to educate and support affected participants, family members, and the community at large.